KMT2A and acute myeloid leukemia: Similar to MLL-AF9-induced AML, the onset of RUNX1-ETO9a-induced AML was delayed in Rag2−/− mice compared to WT mice, and it became more evident with the treatment with DS-5272 (Fig. 5a).